These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10297122)

  • 1. The utility of an organized drug data base in determining contributions to the quality and efficiency of Medicaid programs.
    Roden DR; Kennard LH
    Drug Inf J; 1975; 9(2-3):131-7. PubMed ID: 10297122
    [No Abstract]   [Full Text] [Related]  

  • 2. The ripple effects of a restrictive Medicaid formulary.
    Grabowski H
    Am J Manag Care; 2003 Oct; 9(10):648-9. PubMed ID: 14572174
    [No Abstract]   [Full Text] [Related]  

  • 3. Perspectives. Drug utilization review: apocalypse when?
    Ault A
    Faulkner Grays Med Health; 1992 Feb; 46(8):suppl 4 p.. PubMed ID: 10116064
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative Medicaid drug cost control experiences.
    Kennard LH; Platt WG
    Med Mark Media; 1979 Mar; 14(3):38, 40-3. PubMed ID: 10316799
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of factors influencing antibiotic usage in hospitals.
    Sabath LD; Notto DA
    Prog Clin Biol Res; 1979; 35():65-74. PubMed ID: 538037
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacy benefit management as a quality safeguard.
    Giaquinta D
    Manag Care Interface; 2002 Mar; 15(3):54, 57. PubMed ID: 11925680
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceutical formularies: the right formula for cost and utilization?
    Austin B
    Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
    [No Abstract]   [Full Text] [Related]  

  • 8. The elimination of selected drug products from the Michigan Medicaid formulary: a case study.
    Smith DM; McKercher PL
    Hosp Formul; 1984 May; 19(5):366-72. PubMed ID: 10299510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. States exempt psychiatric drugs in some Medicaid programs.
    Manag Care; 2003 Nov; 12(11):61. PubMed ID: 14666588
    [No Abstract]   [Full Text] [Related]  

  • 10. Exploring the potential link between Medicaid access restrictions, physician location, and health disparities.
    Headen A; Masia N
    Am J Manag Care; 2005 Jan; 11 Spec No():SP21-6. PubMed ID: 15700906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization patterns of cns drugs with varying abuse potential.
    Elmendorf T; Kennard LH; Roden DR; Laventurier MF
    Hosp Formul; 1975 Oct; 10(10):487-90. PubMed ID: 10316670
    [No Abstract]   [Full Text] [Related]  

  • 12. Working with PBMs (pharmacy benefit managers).
    Peterson C
    Healthplan; 1999; 40(2):83-6, 88-9. PubMed ID: 10537477
    [No Abstract]   [Full Text] [Related]  

  • 13. The coming of Medicaid.
    Navarro RP
    Med Interface; 1995 Dec; 8(12):82-3. PubMed ID: 10153523
    [No Abstract]   [Full Text] [Related]  

  • 14. Medicare Part D: how do vulnerable beneficiaries fare?
    Summer L; Nemore P; Finberg J
    Issue Brief (Commonw Fund); 2008 Apr; 35():1-11. PubMed ID: 18536146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escalating need for comparative analysis of drugs within a therapeutic class.
    Giaquinta D
    Manag Care Interface; 2003 Oct; 16(10):32-4. PubMed ID: 14606258
    [No Abstract]   [Full Text] [Related]  

  • 16. How effectively do managed care organizations influence prescribing and dispensing decisions?
    Carroll NV
    Am J Manag Care; 2002 Dec; 8(12):1041-54. PubMed ID: 12500881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prior-authorization programs for controlling drug spending.
    Hamel MB; Epstein AM
    N Engl J Med; 2004 Nov; 351(21):2156-8. PubMed ID: 15548775
    [No Abstract]   [Full Text] [Related]  

  • 18. Relative drug safety and efficacy: any help for the practitioner?
    Rucker TD; Visconti JA
    Am J Hosp Pharm; 1979 Aug; 36(8):1099-101. PubMed ID: 484571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The logical structure of the VIDEOFAR drug data base.
    Caffari B; Raschetti R
    Ann Ist Super Sanita; 1991; 27(2):195-200. PubMed ID: 1755570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of incentive-based formularies on drug utilization and spending.
    Sandy LG; Heady T
    N Engl J Med; 2004 Mar; 350(10):1057. PubMed ID: 15002122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.